Patient-reported outcomes before treatment for localized prostate cancer: are there differences among countries? Data from the True North Global Registry.

INTRODUCTION: Similar Patient-Reported Outcomes (PROs) at diagnosis for localized prostate cancer among countries may indicate that different treatments are recommended to the same profile of patients, regardless the context characteristics (health systems, medical schools, culture, preferences…). The aim of this study was to assess such comparison. METHODS: We analyzed the EPIC-26 results before the primary treatment of men diagnosed of localized prostate cancer from January 2017 onwards (revised data available up to September 2019), from a multicenter prospective international cohort including seven regions: Australia/New Zealand, Canada, Central Europe (Austria / Czech Republic / Germany), United Kingdom, Italy, Spain, and the United States. The EPIC-26 domain scores and pattern of three selected items were compared across regions (with Central Europe as reference). All comparisons were made stratifying by treatment: radical prostatectomy, external radiotherapy, brachytherapy, and active surveillance. RESULTS: The sample included a total of 13,483 men with clinically localized or locally advanced prostate cancer. PROs showed different domain patterns before treatment across countries. The sexual domain was the most impaired, and the one with the highest dispersion within countries and with the greatest medians' differences across countries. The urinary incontinence domain, together with the bowel and hormonal domains, presented the highest scores (better outcomes) for all treatment groups, and homogeneity across regions. CONCLUSIONS: Patients with localized or locally advanced prostate cancer undergoing radical prostatectomy, EBRT, brachytherapy, or active surveillance presented mainly negligible or small differences in the EPIC-26 domains before treatment across countries. The results on urinary incontinence or bowel domains, in which almost all patients presented the best possible score, may downplay the baseline data role for evaluating treatments' effects. However, the heterogeneity within countries and the magnitude of the differences found across countries in other domains, especially sexual, support the need of implementing the PRO measurement from diagnosis.

[Atrial fibrillation in a patient with non-small-cell carcinoma of the lung in the course of paclitaxel therapy]. / Fibrillazione atriale in un paziente affetto da Non Small Cell Lung Cancer in corso di chemioterapia con paclitaxel.

We report a clinical case of a patient with NSCLC who experienced an atrial fibrillation during paclitaxel infusion. Before chemotherapy, his cardiological function was normal. No cardiovascular and/or thyroid associated disease were previously reported. The patient did not receive any drugs with pro-arrhythmic effects. Incidence of cardiovascular toxicity in patients treated with paclitaxel is low, and does not justify strict cardiological monitoring otherwise deserved to patients with preexistent risk factors.

[Asymptomatic pre-excitation. Identification of potential risk using transesophageal pacing]. / Preeccitazione asintomatica. Identificazione del rischio potenziale mediante pacing transesofageo.

Noninvasive assessment of the conducting capability of the accessory pathway (AP) in asymptomatic patients with a preexcitation ECG pattern is desirable, since life-threatening arrhythmias and sudden death may be the first manifestation of the Wolff-Parkinson-White (WPW) syndrome. To investigate whether in patients with preexcitation ECG pattern the absence of clinical arrhythmias excludes the potential for rapid ventricular responses, transesophageal atrial pacing (TAP) was performed in 11 subjects (9 male, 2 female), aged 5 to 43 years. The extrastimulus technique was used in order to define the refractory periods and in the attempt to induce reciprocating tachycardia. Incremental TAP up to the occurrence of block in the AP was instituted, and attempts to induce atrial fibrillation (AF) with rapid burst pacing were made. One to one atrioventricular conduction over the AP at progressively increased cycle lengths (CLs), and the shortest R-R interval between pre-excited beats during induced AF were evaluated. The following findings were considered predictors of potential life-threatening arrhythmias: 1) anterograde refractory period of the AP equal to or shorter than 250 ms; 2) one to one AP conduction at CLs shorter than 300 ms; 3) shortest R-R interval, during induced AF, less than 250 ms. Sustained reciprocating tachycardia could not be induced in all patients in spite of the use of the use of an aggressive stimulation protocol. The anterograde refractory period of the AP could not be defined in 9 patients. In the remaining 2 this parameter was longer than 250 ms. In 8 patients (72%), the shortest CL maintaining 1:1 AP conduction ranged from 220 to 280 ms (mean 253 +/- 19).(ABSTRACT TRUNCATED AT 250 WORDS)

[Electrophysiologic significance of the electric alternans in supraventricular tachycardia]. / Significato elettrofisiologico dell'alternanza elettrica nella tachicardia sopraventricolare.

To investigate the electrophysiologic significance of QRS alternans during narrow QRS tachycardia, transesophageal atrial pacing and recording was performed in 24 patients with a history of paroxysmal supraventricular tachycardia. Standard electrocardiograms (ECG) showed ventricular preexcitation in 15 patients and normal QRS pattern in 9. The ventriculo-atrial interval during tachycardia, as defined by means of transesophageal electrogram, allowed tentative diagnosis of the tachycardia mechanism. A 12-lead ECG was recorded either during spontaneous or induced tachycardia, as well as during transesophageal atrial pacing at increasing rates. Electrical alternans occurred spontaneously in 8 patients (33%, Group A): 5 with accessory pathway reentry (mean VA: 136 +/- 43 ms), 3 with intranodal reentry (mean VA: 48.3 +/- 43 ms). Tachycardia rate ranged between 170 and 230 b/min (mean 200.7 +/- 16). In 2 patients alternation of the QRS occurred only in the presence of a heart rate exceeding 180 and 190 b/min, respectively. The amplitude of QRS remained stable during tachycardia in 16 patients (67%, Group B): 14 with accessory pathway reentry (mean VA: 137.5 +/- 32 ms), 2 with intranodal reentry (mean VA: 45 +/- 7 ms). In this group, the tachycardia rate ranged from 150 to 210 b/min (mean 175 +/- 12). Incremental transesophageal atrial pacing up to rates equal to that of tachycardia was performed in 5 patients of Group A and in 8 of Group B. Electrical alternans could not be induced in both groups with pacing at progressively increasing rates. In contrast, the phenomenon was elicited in 2 patients of Group A when an abrupt pacing at the same rate that had showed the spontaneous occurrence of QRS alternans was instituted.(ABSTRACT TRUNCATED AT 250 WORDS)

[Personal experiences concerning the usefulness of the exercise test in the diagnosis of ischemic heart disease in aged patients with atypical symptomatology]. / Esperienze personali sull'utilità della prova da sforzo nella diagnosi di cardiopatia ischemica in pazienti anziani con sintomatologia atipica.

Present-day therapeutic possibilities, both medical and surgical, make it mandatory for the practitioner to identify elderly patients with ischemic heart disease which in these patients often presents with atypical symptoms. Twenty elderly patients with not clear-cut symptoms of coronary disorder were submitted to an exercise test on a walking belt. In 14 (70%) the test was positive and in 8 of these 14 cases previous dynamic electrocardiography had not yielded signs of ischemia. The authors consider correctly performed exercise testing the best means for identifying the often not diagnosed coronary impairment of elderly subjects.